Test Price
2,800 AED✅ Home Collection Available
USP9X Gene Mental Retardation, X‑linked Type 99 – NGS Diagnostic Test in Dubai
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity for pathogenic variants in USP9X via ISO 9001:2015 accredited Next‑Generation Sequencing (NGS) with bioinformatic validation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary telephonic post‑test clinical interpretation session with a DHA‑licensed Consultant Medical Geneticist.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731 – most UAE health insurance policies accepted.
- Price: 2,800 AED (inclusive of genetic counselling and detailed molecular report).
- Turnaround Time: 3–4 weeks from sample receipt.
Test Overview & Methodology
The USP9X gene test employs deep Next‑Generation Sequencing (NGS) to detect single‑nucleotide variants, small insertions/deletions, and copy‑number variants responsible for X‑linked mental retardation type 99. This molecular diagnostic tool is essential for neurologists and clinical geneticists to confirm a genetic aetiology in patients with unexplained intellectual disability, enabling personalised care, accurate recurrence risk assessment, and informed family planning. All pathogenic findings are independently confirmed by Sanger sequencing.
Comparative Advantages: NGS Versus Standard Sanger Sequencing
| Parameter | Our USP9X NGS Test | Standard Single‑Gene Sanger Sequencing |
|---|---|---|
| Precision | 99.9% sensitivity for SNVs, indels, and CNVs via deep NGS with bioinformatic validation | ~98% for point mutations; limited CNV detection |
| Methodology | Next‑Generation Sequencing (Illumina platform) followed by Sanger confirmation of pathogenic findings | Sanger sequencing of individual exons |
| Turnaround Time | 3–4 weeks from sample receipt | 6–8 weeks (often requires multiple reactions) |
| UAE Logistics | Home collection via cold‑chain, DHA‑compliant reporting | Clinic visit required; limited home service |
Physician Insight & Safety Protocols
“A molecular genetic result is a critical piece of the diagnostic puzzle, but it must always be correlated with the full clinical phenotype, neuroimaging findings, and three‑generation family history. As a Consultant Medical Geneticist, I interpret every USP9X variant in the context of the patient’s complete health trajectory. My team and I are available for a complimentary post‑test telephonic session to discuss your result and its implications for you and your family.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medication (including anti‑epileptics or psychiatric drugs) without direct consultation with your treating physician. Abrupt cessation can cause serious withdrawal effects or relapse.
Exclusion Criteria & Red Flags
- Active febrile illness or recent blood transfusion – postpone testing for 4 weeks.
- Known haematological malignancy that may affect DNA extraction from whole blood – an alternative sample (buccal swab or extracted DNA) must be discussed with the laboratory.
- Emergencies: If the patient experiences sudden loss of consciousness, status epilepticus, or severe behavioural regression, seek immediate emergency medical care – do not delay genetic testing.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of the USP9X gene test for X‑linked mental retardation?
This NGS test identifies pathogenic variants in the USP9X gene causing X‑linked intellectual disability type 99. It enables a precise molecular diagnosis, guides personalised management, and provides accurate recurrence risk information for family planning.
2. Can I give a sample at home, and how should I prepare?
Yes, our VIP Mobile Phlebotomy service collects a peripheral whole blood sample at your home between 8 AM and 11 PM daily. No fasting is required. The sample is transported via temperature‑controlled cold chain to our ISO‑accredited laboratory.
3. Will my health insurance cover this genetic test in the UAE?
Most UAE health insurance policies cover medically necessary genetic tests when ordered by a DHA‑licensed neurologist or clinical geneticist. Our team verifies your coverage directly via WhatsApp at +971 54 548 8731.
4. What happens after my result is ready?
You will receive a comprehensive molecular report detailing any detected variants, their pathogenicity classification, and clinical interpretation. A complimentary telephonic session with a Consultant Medical Geneticist is included to explain the results and their implications.
5. How long does the test take, and when will I receive the report?
The turnaround time is 3–4 weeks from the date the sample is received at the laboratory. The report is delivered electronically and via secure courier.
UAE Regulatory & Data Privacy Adherence
Your Data, Your Trust – Fully Compliant with UAE Law
All genetic testing and data handling at DNA Labs UAE comply with:
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, processing, and storage of your personal and genomic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – regulating digital health records, telemedicine, and electronic data exchange.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability – ensuring clinical safety, informed consent, and professional accountability in diagnostic procedures.
Our laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and operates under DHA Facility License No. 1143. For home collection, WhatsApp support, or direct billing verification: +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | USP9X Gene Mental Retardation, X‑linked Type 99 – NGS Diagnostic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube); alternative sample types (buccal swab, extracted DNA) by prior laboratory approval |
| Methodology Used | Next‑Generation Sequencing (NGS) on Illumina platform with bioinformatic variant calling and Sanger confirmation of all pathogenic findings |
| ICD‑10‑CM Code | F78 (Other intellectual disability) |
| LOINC Code | 55233-1 (Genetic analysis for a specific gene mutation) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians